Wednesday, August 02, 2017 3:23:50 PM
I'll have to listen to the CC to be able to understand their theory for this action.
Were they obligated to make a decision on this at this point? It seems extremely early to have to decide on this, while the ink of the original contract is barely dry.
Too make this call before any patient has been dosed makes we wonder why they needed to partner this drug for a couple of million dollars if they had that much confidence. On the other hand, Momenta's record of new drug development compares right in line with it's legal wins.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM